- Companies
- Capsugel
Capsugel Acquisition, Valuation, Funding & Investors
Capsugel was acquired by Lone Star Funds for $2.2B in March 2026, a 1.7x multiple on $1.3B of revenue.
Capsugel acquisition price
$2.2B
Acquired by Lone Star Funds · Mar 2026
Capsugel revenue at acquisition
$1.3B
Last twelve months · Mar 2026
Capsugel revenue multiple at acquisition
1.7x
EV/Revenue · Mar 2026
Capsugel EBITDA multiple at acquisition
6.9x
EV/EBITDA · Mar 2026
About Capsugel
Capsugel is a global leader in two-piece hard capsules and drug delivery systems serving pharmaceutical and nutraceutical companies worldwide with manufacturing sites in Europe, North America, and Asia.
Founded
1963
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Product sales
Revenue
$1.3B (Mar 2026)
Valuation
$2.2B (acquired Mar 2026)
Sectors
Capsugel Acquisition
Capsugel was acquired by Lone Star Funds for $2.2B on 5 March 2026.
The acquisition price implies a 1.7x revenue and 6.9x EBITDA multiple on $1.3B of revenue.
| Acquirer | Date | Type | Price | EV/Revenue | EV/EBITDA |
|---|---|---|---|---|---|
| 5 Mar 2026 | PE buyout | $2.2B | 1.7x | 6.9x |
Capsugel Funding History
Capsugel has raised 1 funding round.
| Date | Stage | Investors |
|---|---|---|
| Mar 2026 | Undisclosed stage | Lonza Group (lead) |
Who has invested in Capsugel?
1 investor has backed Capsugel across its funding rounds, including Lonza Group.
Lead investors include Lonza Group.
Capsugel Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 Capsugel investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAcquisitions by Capsugel
Capsugel has acquired 1 company to date.
Last acquisition by Capsugel was on December 14th 2015. Capsugel acquired Xcelience for undisclosed valuation.
Latest Acquisitions by Capsugel
| Description | Xcelience is a San Diego-based contract development and manufacturing organization offering end-to-end services for oral solid dosage forms. Its suite includes preformulation screening, spray drying, analytical method development under USP/ICH guidelines, formulation optimization, and cGMP manufacturing up to 100,000 units. Xcelience provides micronization for poorly soluble APIs, global clinical supply chain logistics, and comparator packaging for bioequivalence trials. The company serves biotech firms transitioning to commercial scale with QbD approaches and FDA Type C filings. |
| HQ Country | |
| HQ City | Tampa, FL |
| Deal Date | 14 Dec 2015 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Capsugel acquisitions and their M&A valuation multiples. Start Free Trial | |
Capsugel Competitors
Capsugel competitors include listed companies like Alamar Biosciences, Draegerwerk, Bausch Health and Butterfly Network, and private ones like ArsenalBio and BioRay Pharmaceuticals.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $74M | ($27M) | $2.2B | 19.1x | ||
| Publicly listed | $4B | $449M | $2.1B | 0.6x | ||
| Publicly listed | $10B | $3.1B | $2.1B | 2.1x | ||
| Publicly listed | $98M | ($73M) | $2.1B | 17.6x | ||
| Private | - | - | $1.9B | - | ||
| Private | $131M | - | $1.9B | 14.5x |
Capsugel Public Comps
Capsugel is no longer listed, but its public comps include GN Store Nord, Alamar Biosciences, Jeol, Rigaku, UFP Technologies, Draegerwerk, Bausch Health, Butterfly Network, Oxford Nanopore Technologies and Fukuda Denshi.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $2.6B | $382M | 1.4x | 2.0x | 9.5x | 18.5x | |||
| $74M | ($27M) | 27.3x | 19.1x | (74.8x) | (42.3x) | |||
| $1.2B | $224M | 1.9x | 2.0x | 9.6x | 10.7x | |||
| $606M | $140M | 4.1x | 3.9x | 17.9x | 16.2x | |||
| $603M | $112M | 3.7x | 3.5x | 20.3x | 17.4x | |||
| $4B | $449M | 0.6x | 0.6x | 5.2x | 5.1x | |||
| $10B | $3.1B | 2.2x | 2.1x | 7.2x | 5.7x | |||
| $98M | ($73M) | 20.6x | 17.6x | (27.5x) | (93.5x) | |||
This data is available for Pro users. Sign up to see all Capsugel competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Capsugel
| When was Capsugel founded? | Capsugel was founded in 1963. |
| Where is Capsugel headquartered? | Capsugel is headquartered in Morristown, NJ, United States. |
| Is Capsugel publicly listed? | No, Capsugel was acquired by Lone Star Funds in March 2026. |
| Who acquired Capsugel? | Capsugel was acquired by Lone Star Funds in March 2026. |
| How much was Capsugel acquired for? | Capsugel was acquired for $2.2B in March 2026, a 1.7x revenue multiple. |
| What was Capsugel's last funding round? | Capsugel's last funding round was a undisclosed-stage round in March 2026, led by Lonza Group. |
| Who are Capsugel's investors? | Capsugel's investors include Lonza Group. |
| Which companies are comparable to Capsugel? | Companies comparable to Capsugel include Alamar Biosciences, Draegerwerk, Bausch Health, Butterfly Network, ArsenalBio and BioRay Pharmaceuticals. |
| How many companies has Capsugel acquired? | Capsugel has acquired 1 company, including Xcelience. |
See companies similar to Capsugel
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




